Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|March 15, 2024
Synthetic Approaches to the New Drugs Approved During 2022Scott P France, Erick A Lindsey, Emma L McInturff, et al.Chemistry & Biology|December 17, 2015
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic OpportunitiesEugene L Piatnitski Chekler, Jessica A Pellegrino, Thomas A Lanz, et al.Journal of Medicinal Chemistry|March 30, 2021
Synthetic Approaches to the New Drugs Approved during 2019Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.ACS Medicinal Chemistry Letters|February 16, 2023
Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistsMark E Schnute, John I Trujillo, Katherine L Lee, et al.Journal of Medicinal Chemistry|July 14, 2022
Synthetic Approaches to the New Drugs Approved During 2020Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.Journal of Medicinal Chemistry|August 1, 2023
Synthetic Approaches to the New Drugs Approved During 2021Emma L McInturff, Scott P France, Carolyn A Leverett, et al.Journal of Medicinal Chemistry|June 14, 2024
Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1Mark Sabat, Daniel W Carney, Gloria Hernandez-Torres, et al.Journal of Medicinal Chemistry|August 22, 2018
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistMark E Schnute, Mattias Wennerstål, Jennifer Alley, et al.Pageof 3